Hepatits-C-virus-associated cryoglobulinemia. Pathogenesis, diagnosis and treatment;Hepatitis-C-virus-assoziierte kryoglobulinämie. Pathogenese, diagnostik und therapie

Medizinische Klinik

Volumn 97, Issue 10, 2002, Pages 601-608

  Staak, Jan Oliver ^a   Glossmann, Jan Peter ^a   Diehl, Volker ^a   Josting, Andreas ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

B cell non Hodgkin's lymphoma; Cryoglobulinemia; Hepatitis C; Immunocomplexes; Interferon ; Lymphoproliferative disorders; Plasmapheresis; Ribavirin; Vasculitis

Indexed keywords

CRYOGLOBULIN; IMMUNOGLOBULIN M; INTERFERON; PROTEIN BCL 2; RHEUMATOID FACTOR; RIBAVIRIN; RITUXIMAB;

ANTIGEN ANTIBODY COMPLEX; ARTHRALGIA; AUTOIMMUNE DISEASE; B CELL LYMPHOMA; B LYMPHOCYTE ACTIVATION; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; GENE ACTIVATION; GLOMERULONEPHRITIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE PROLIFERATION; MUSCLE WEAKNESS; NEUROPATHY; NONHODGKIN LYMPHOMA; PATHOGENESIS; PURPURA; REVIEW; VASCULITIS;

ANTIVIRAL AGENTS; CRYOGLOBULINEMIA; DIAGNOSIS, DIFFERENTIAL; HEPATITIS C, CHRONIC; HUMANS; IMMUNOGLOBULIN M; INTERFERON-ALPHA; PLASMAPHERESIS; RHEUMATOID FACTOR;

HEPATITIS C VIRUS; PURPURA;

EID: 0037107517     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-002-1201-5     Document Type: Review

References (93)

1. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327:1490-5.
2. Andreone P, Zignego AL, Cursaro C, et al. Prevalence of monoclonal gammopathies in patients with 2 hepatitis C virus infection. Ann Intern Med 1998;129:294-8.
3. Bloch KJ. Cryoglobulinemia and hepatitis C virus. N Engl J Med 1992;327:1521-2.
4. Bonomo L, Casato M, Afeltra A, et al. Treatment of idiopathic mixed cryoglobulinemia with alpha interferon. Am J Med 1987;83:726-30.
5. Borgonovo G, d'Oiron R, Amato A, et al. Primary lymphoplasmacytic lymphoma of the liver associated with a serum monoclonal peak of IgG kappa. Am J Gastroenterol 1995;90:137-40.
6. Brouet JC, Clauvel JP, Danon F, et al. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974;57:775-88.
7. Cacoub P, Fabiani FL, Musset L, et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 1994;96:124-32.
8. Casato M, Lagana B, Antonelli G, et al. Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia. Blood 1991; 78:3142-7.
9. Cid MC, Hernandez-Rodriguez J, Robert J, et al. Interferon-alpha may exacerbate cryoblobulinemia-related ischemic manifestations: An adverse effect potentially related to its anti-angiogenic activity. Arthritis Rheum 1999;42:1051-5.
10. Collier JD, Zanke B, Moore M, et al. No association between hepatitis C and B-cell lymphoma. Hepatology 1999;29:1259-61.
11. Crotta S, Stilla A, Wack A, et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med 2002;195:35-41.
12. Daghestani L, Pomeroy C. Renal manifestations of hepatitis C infection. Am J Med 1999;106:347-54.
13. Dammacco F, Bonomo L. Crioglobulinemia e piroglobulinemia. In: Dammacco F, ed. Immunologia in Medicina. Milano: Edi-Ermes, 1989:599.
14. Dammacco F, Gatti P, Sansonno D. Hepatitis C virus infection, mixed cryoglobulinemia, and non-Hodgkin's lymphoma: An emerging picture. Leuk Lymphoma 1998;31:463-76.
15. Dammacco F, Sansonno D. Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia. Clin Exp Immunol 1992;87:352-6.
16. Dammacco F, Sansonno D. Mixed cryoglobulinemia as a model of systemic vasculitis. Clin Rev Allergy Immunol 1997;15:97-119.
17. Dammacco F, Sansonno D, Cornacchiulo V, et al. Hepatitis C virus infection and mixed cryoglobulinemia: A striking association. Int J Clin Lab Res 1993;23:45-9.
18. Dammacco F, Sansonno D, Han JH, et al. Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: A long-term, randomized, controlled study. Blood 1994;84:3336-43.
19. Dammacco F, Sansonno D, Piccoli C, et al. The cryoglobulins: An overview. Eur J Clin Invest 2001;31:628-38.
20. Davis GL, Esteban-Mur R, Rustgi V, et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med 1998; 339:1493-9.
21. De Rosa G, Gobbo ML, De Renzo A, et al. High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy. Am J Hematol 1997;55:77-82.
22. De Vita S, Sacco C, Sansonno D, et al. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood 1997;90:776-82.
23. De Vita S, Sansonno D, Dolcetti R, et al. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 1995;86:1887-92.
24. De Vita S, Zagonel V, Russo A, et al. Hepatitis C virus, non-Hodgkin's lymphomas and hepatocellular carcinoma. Br J Cancer 1998;77:2032-5.
25. Donada C, Crucitti A, Donadon V, et al. Interferon and ribavirin combination therapy in patients with chronic hepatitis C and mixed cryoglobulinemia. Blood 1998;92:2983-4.
26. Ellis M, Rathaus M, Arniel A, et al. Monoclonal lymphocyte proliferation and bcl-2 rearrangement in essential mixed cryoglobulinaemia. Eur J Clin Invest 1995;25:833-7.
27. Ferri C, Caracciolo F, Zignego AL, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994;88:392-4.
28. Ferri C, Greco F, Longombardo G, et al. Hepatitis C virus antibodies in mixed cryoglobulinemia. Clin Exp Rheumatol 1991;9:95-6.
29. Ferri C, Matzo E, Longombardo G, et al. Interferon-alpha in mixed cryoglobulinemia patients: A randomized, crossover-controlled trial. Blood 1993; 81:1132-6.
30. Geltner D. Therapeutic approaches in mixed cryoglobulinemia. Springer Semin Immunopatho 1998;10:103-13.
31. Geltner D, Franklin EC. Frangione B. Antiidiotypic activity in the IgM fractions of mixed cryoglobulins. J Immunol 1980;125:1530-5.
32. Germanidis G, Haioun C, Dhumeaux D, et al. Hepantis C virus infection, mixed cryoglobulinemia, and B-cell non-Hodgkin's lymphoma. Hepatology 1999;30:822-3.
33. Germanidis G, Haioun C, Pourquier J, et al. Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center. Blood 1999;93:1778-9.
34. Gumber SC, Chopra S. Hepatitis C: A multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995;123:615-20.
35. Heer M, Joller-Jemelka H, Fontana A, et al. Monoclonal gammopathy in chronic active hepatitis. Liver 1984;4:255-63.
36. Invernizzi F, Galli M, Serino G, et al. Secondary and essential cryoglobulinemias. Frequency, nosological classification, and long-term follow-up. Acta Haematol 1983;70:73-82.
37. Ivanovski M, Silvestri F, Pozzato G, et al. Somatic mutation, clonal diversity, and preferential expression of the VH51pl/VLkv325 immunoglobulin gene combination in hepatitis C virus associated immuncytomas. Blood 1998;91:2433-42.
38. Jeannette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
39. Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993;328:465-70.
40. Kaplan AA. Therapeutic plasma exchange for the treatment of rapidly progressive glomerulonephritis. Ther Apher 1997;1:255-9.
41. Khella SL, Frost S, Hermann GA, et al. Hepatitis C infection, cryoglobulinemia, and vasculitic neuropathy. Treatment with interferon alfa: Case report and literature review. Neurology 1995; 45:407-11.
42. Kiyomoto H, Hitomi H, Hosotani Y, et al. The effect of combination therapy with interferon and cryofiltration on mesangial proliferative glomerulonephritis originating from mixed cryoglobulinemia in chronic hepatitis C virus infection. Ther Apher 1999;3:329-33.
43. Lamprecht P, Schnabel A, Gross WL. [Hepatitis C virus-associated cryoglobulinemic vasculitis. Physiopathology, diagnosis and therapy]. Dtsch Med Wochenschr 1998;123:637-42.
44. Lerner AB, Watson CJ. Studies of cryoglobulins. 1. Unusual purpura associated with the presence of high concentration of cryoglobulin (cold precipitable serum globulin). Am J Med Sci 1947;314:410-5.
45. Levey JM, Bjornsson B, Banner B, et al. Mixed cryoglobulinemia in chronic hepatitis C infection. A clinicopathologic analysis of 10 cases and review of recent literature. Medicine (Baltimore) 1994; 73:53-67.
46. Levo Y, Gorevic PD, Kassab HJ, et al. Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med 1977;296:1501-4.
47. Lunel F, Cacoub P. Treatment of autoimmune and extrahepatic manifestations of hepatitis C virus infection. J Hepatol 1999;31:210-6.
48. Maire MA, Mittey M, Lambert PH. The presence of cryoprecipitable immunoglobulins in normal human sera may reflect specific molecular interactions. Autoimmunity 1989;2:155-64.
49. Mangia A, Clemente R, Musto P, et al. Hepatitis C virus infection and monoclonal gammopathies not associated with cryoglobulinemia. Leukemia 1996; 10:1209-13.
50. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet 2001;358:958-65.
51. Mazzaro C, Franzin F, Tulissi P, et al. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy. Cancer 1996;77:2604-13.
52. Mazzaro C, Zagonel V, Monfardini S, et al. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 1996;94:544-50.
53. McColl MD, Singer IO, Tait KC, et al. The role of hepatitis C virus in the aetiology of non-Hodgkins lymphoma - A regional association? Leuk Lymphoma 1997;26:127-30.
54. Meltzer M, Franklin EC. Cryoglobulinemia: A study of 29 patients. I. JgG and IgM cryoglobulins and factors effecting cryoprecipitability. Am J Med 1966;40:828-36.
55. Misiani R, Bellavita P, Fenili D, et al. Interferon alfa2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994;330:751-6.
56. Monteverde A, Ballare M, Pilen S. Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia. Springer Seminars of Immunopathology 1997;19:99-110.
57. Musset L, Diemert MC, Taibi F, et al. Characterization of cryoglobulins by immunoblotting. Clin Chem 1992;38:798-802.
58. Mussini C, Ghini M, Mascia MT, et al. HCV and monoclonal gammopathies. Clin Exp Rheumatol 1995;13:Suppl 13:45-9.
59. Origgi L, Vanoli M, Carbone A, et al. Central nervous system involvement in patients with HCVrelated cryoglobulinemia. Am J Med Sci 1998; 315:208-10.
60. Pascual M, Perrin L, Giostra E, et al. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 1990;162:569-7.
61. Pawlotsky JM, Dhumeaux D, Bagot M. Hepatitis C virus in dermatology. A review. Arch Dermatol 1995;131:1185-93.
62. Pawlotsky JM, Roudot-Thoraval F, Simmonds P, et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995;122:169-73.
63. Pileri P, Uematsu Y, Campagnoli S, et al. Binding of hepatitis C virus to CD81. Science 1998; 282:938-41.
64. Poetsch M, Weber-Matthiesen K, Plendl HJ, et al. Detection of the t(14;18) chromosomal translocation by interphase cytogenetics with yeast-artificial-chromosome probe in follicular lymphoma and nonneoplastic lymphoprilferation. J Clin Oncol 1996; 14:963-9.
65. Poynard T, Marcellin P, Lee SS, et al. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet 1998; 352:1426-32.
66. Pozzato G, Mazzaro C, Crovatto M, et al. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 1994;84:3047-53.
67. Rambusch EG, Manns MP. [Extrahepatic manifestations of hepatitis C infection]. Z Gastroenterol 1998;36:579-86.
68. Ray RB, Meyer K, Ray R. Suppression ofapoptotic cell death by hepatitis C core protein. Virology 1996;226:176-82.
69. Reichard O, Norkrans G, Fryden A, et al. Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group. Lancet 1998;351:83-7.
70. Ryan J, Wallace S, Jones P, et al. Primary hepatic lymphoma in a patient with chronic hepatitis C. J Gastroenterol Hepatol 1994;9:308-10.
71. Sansonno D, De Vita S, Cornacchiulo V, et al. Detection and distribution of hepatitis C virus-related proteins in lymph nodes of patients with type II mixed cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation. Blood 1996; 88:4638-45.
72. Sansonno D, Gesualdo L, Manno C, et al. Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology 1997;25:1237-44.
73. Sansonno D, Lotesoriere C, Cornacchiulo V, et al. Hepatitis C virus infection involves CD34(+) hematopoietic progenitor cells in hepatitis C virus chronic carriers. Blood 1998;92:3328-37.
74. Satoh T, Yamada T, Nakano S, et al. The relationship between primary splenic malignant lymphoma and chronic liver disease associated with hepatitis C virus infection. Cancer 1997;80:1981-8.
75. Schafer DF, Sorrell MF. Conquering hepatitis C, step by step. N Engl J Med 2000;343:1723-4.
76. Schott P, Polzien F, Muller-Issberner A, et al. In vitro reactivity of cryoglobulin IgM and IgG in hepatitis C virus-associated mixed cryoglobulinemia. J Hepatol 1998;28:17-26.
77. Scott DG, Bacon PA, Elliott PJ, et al. Systemic vasculitis in a district general hospital 1972-1980: Clinical and laboratory features, classification and prognosis of 80 cases. QJ Med 1982;51:292-311.
78. Siami FS, Siami GA. Cryofiltration apheresis in the treatment of cryoprecipitate induced diseases. Ther Apher 1997;1:58-62.
79. Silvestri F, Barillan G, Fanin R, et al. Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma. Ann Oncol 1998; 9:499-504.
80. Silvestri F, Pipan C, Barillan G, et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996;87:4296-301.
81. Suzuki H, Takei T, Tsufi H, et al. Membranoproliferative glomerulonephritis and demyelinating neuropathy caused by type II mixed cryoglobulinemia associated with HCV infection. Intern Med 2000;39:397-400.
82. Tseng CT, Klimpel GR. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med 2002;195:43-9.
83. Vallisa D, Berte R, Rocca A, et al. Association between hepatitis C virus and non-Hodgkin's lymphoma, and effects of viral infection on histologic subtype and clinical course. Am J Med 1999; 106:556-60.
84. Viala JJ, Trepo C, Creyssel R, et al. [Monoclonal gammopathy, apparently non-myelomatous, associated with non-A non-B hepatitis antigen]. Nouv Presse Med 1982;11:52.
85. Vital C. Deminiere C, Lagueny A, et al. Peripheral neuropathy with essential mixed cryoglobulinemia: Biopsies from 5 cases. Acta Neuropathol 1988; 75:605-10.
86. Weiner SM, Berg T, Berthold H, et al. A clinical and virological study of hepatitis C virus-related cryoglobulinemia in Germany. J Hepatol 1998; 29:375-84.
87. Wintrobe MM, Buell MV. Hyperproteinemia associated with multiple myeloma. Bull John Hopkins Hosp 1933;52:156-65.
88. Zaja F, Russo D, Fuga G, et al. Pituximab for the treatment of type II mixed cryoglobulinemia. Haematologica 1999;84:1157-8.
89. Zignego AL, Ferri C, Giannini C, et al. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 1996;124:31-4.
90. Zuckerman E, Keren D, Slobodin G, et al. Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha. J Rheumatol 2000;27:2172-8.
91. Zuckerman E, Zuckennan T. Hepatitis C and B-cell lymphoma: The hemato-hepatologist linkage. Blood Rev 2002;16:119-25.
92. Zuckerman E, Zuckerman T, Levine AM, et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997; 127:423-8.
93. Zuckerman E, Zuckerman T, Sahar D, et al. bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection. Br J Haematol 2001;112:364-9.